Malignant fibrous histiocytoma overview: Difference between revisions
Varun Kumar (talk | contribs) |
No edit summary |
||
| Line 13: | Line 13: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 19:22, 24 August 2015
|
Malignant fibrous histiocytoma Microchapters |
|
Differentiating Malignant Fibrous Histiocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Malignant fibrous histiocytoma overview On the Web |
|
American Roentgen Ray Society Images of Malignant fibrous histiocytoma overview |
|
Directions to Hospitals Treating Malignant fibrous histiocytoma |
|
Risk calculators and risk factors for Malignant fibrous histiocytoma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Malignant fibrous histiocytoma (MFH) is a type of cancer that is the most common soft tissue sarcoma of late adult life, most commonly occurring between age 50-70. In rare cases MFH does occur in children, but it is usually in a less aggressive form. However, malignant tumors have occurred in children as young as 13. It occurs more often in caucasians than those of African or Asian descent. Its male:female predominance is 2:1.
Treatment
Treatment consists of surgical removal (the extent of which ranges from tumor excision to limb amputation depending on the tumor) and in some cases chemotherapy.